<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01439295</url>
  </required_header>
  <id_info>
    <org_study_id>University of Montreal</org_study_id>
    <secondary_id>CIHR246505</secondary_id>
    <nct_id>NCT01439295</nct_id>
  </id_info>
  <brief_title>Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia</brief_title>
  <official_title>Urinary Ascorbyl Peroxide as an Early Biological Marker of Bronchopulmonary Dysplasia in Preterm Infants Less Than 33 Weeks of Gestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Justine's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Justine's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary ascorbyl peroxide level in the first week of life will be a good predictor of
      Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study uses ascorbyl peroxide as representative of oxidative stress in premature infants
      on parenteral nutrition and aims to test the correlation of this metabolite and the different
      major neonatal outcomes 'mainly bronchopulmonary dysplasia).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bronchopulmonary Dysplasia</measure>
    <time_frame>4 Months</time_frame>
    <description>To correlate the level of urinary Ascorbyl peroxide and BPD. Full diagnosis and classification (to mild, moderate or severe) is at 36 weeks of corrected age; so even for most premature infants (like 23 weeks of gestation) there will be a need for follow up for less than 4 month to have the final diagnosis at 36 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The redox status (in blood)</measure>
    <time_frame>First week of life (week 1) and 36 semaines CA</time_frame>
    <description>Testing the correlation between the urinary level of ascorbyl peroxide and the redox status in the blood at 5 to 7 days of life. Measuring the Redox potential at 36 weeks corrected age to investigate long term effect of early oxidative stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major neonatal outcomes (NEC, ROP, PDA, IVH, PVL)</measure>
    <time_frame>4 Months</time_frame>
    <description>These outcomes are the major neonatal outcomes for preterm infants, we would test the correlation between ascorbyl peroxide (as marker of oxidative stress) and like Necrotising enterocolotis (NEC), Retinopathy of prematurity (ROP),patent ductus arteriosis(PDA), intraventricular hemorrhage (IVH) and periventricular leucomalacia (PVL).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>Preterm less than 33 weeks</arm_group_label>
    <description>This cohort will be composed of premature infants born before 33 weeks of gestational age, admitted to the neonatal intensive care unit at Sainte-Justine hospital and receiving parenteral nutrition (PN) during their first week of life.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine sample (650 µl) Blood sample (500 µl)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm infants less than 33 weeks of getation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm infants less than 33 weeks of gestation&lt;

          -  Admission to CHU Sainte-JUstien neonatal intensive care unit

          -  Receiving Parenteral nutrition during the first week of life

          -  Parental consent

        Exclusion Criteria:

          -  Major congenital anomalies

          -  Sever perinatal asphyxia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>23 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Mohamed, Mb CHB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Montreal, Sainte Justine Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-claude Lavoie, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Montreal, Sainte-Justine hospital research center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Montreal, Sainte-Justine Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.clinchem.org/cgi/content/abstract/50/1/135</url>
    <description>Light-Induced Byproducts of Vitamin C in Multivitamin Solutions</description>
  </link>
  <link>
    <url>http://www.clinchem.org/cgi/content/full/51/8/1462</url>
    <description>Association between Hydrogen Peroxide-Dependent Byproducts of Ascorbic Acid and Increased Hepatic Acetyl-CoA Carboxylase Activity</description>
  </link>
  <link>
    <url>http://journals.lww.com/pedresearch/Fulltext/2010/09000/Neonatal_Exposure_to_Oxidants_Induces_Later_in.2.aspx</url>
    <description>Neonatal Exposure to Oxidants Induces Later in Life a Metabolic Response Associated to a Phenotype of Energy Deficiency in an Animal Model of Total Parenteral Nutrition</description>
  </link>
  <link>
    <url>http://journals.lww.com/pedresearch/pages/articleviewer.aspx?year=1998&amp;issue=05000&amp;article=00007&amp;type=abstract</url>
    <description>Paradoxical Role of Ascorbic Acid and Riboflavin in Solutions of Total Parenteral Nutrition: Implication in Photoinduced Peroxide Generation</description>
  </link>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2011</study_first_submitted>
  <study_first_submitted_qc>September 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2011</study_first_posted>
  <last_update_submitted>November 17, 2015</last_update_submitted>
  <last_update_submitted_qc>November 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Justine's Hospital</investigator_affiliation>
    <investigator_full_name>Ibrahim Mohamed</investigator_full_name>
    <investigator_title>Adjunct professor of peditarics, division of neonatology</investigator_title>
  </responsible_party>
  <keyword>Ascorbyl peroxide</keyword>
  <keyword>Bronchopulmonary dysplasia</keyword>
  <keyword>Redox status</keyword>
  <keyword>Necrotising entercolitis</keyword>
  <keyword>Retinopathy of prematurity</keyword>
  <keyword>Patent ductus arteriosus</keyword>
  <keyword>Intraventricular hemorrhage</keyword>
  <keyword>Periventricular leucomalacia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

